A Major Power in New Drugs – It's Time to Have Its Own Voice.
Jun 11,2026
Strategic Reflections on China's Pharmaceutical Voice
Jun 10,2026
Before the conference in July, spots for inviting friends are limited – first come, first served.
Lin Jinzhong of RNAimmune: Neither the Future nor the Past — Focus on Doing the Present Well
Jun 10,2026
What's Next for mRNA?
Why One American VC Is Betting Against Biotech Decoupling
Jun 09,2026
RA Capital General Counsel Discusses the China-U.S. Biopharma Narrative
Agenda Update: The Booming Radiopharmaceuticals Session
Jun 08,2026
Bringing together top scientists, clinical experts, and industry leaders in the radiopharmaceutical field.
Full Agenda Unveiled: China-Japan Cooperation Session
Jun 08,2026
Leveraging the Japanese Market to Drive Globalization Strategy
Dense Blockbusters, Intense Activity: Oligonucleotides Enter the Harvest Period
Jun 07,2026
Exclusive Interview with Li Hao, Preclinical CMO at Convalife (Kanglonghua)